Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.9K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

2.1K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.1K
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

11.3K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
11.3K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

370
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
370
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

642
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
642
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

104
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
104

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors influencing the indication of coronary angiography in patients presenting with chest pain unspecified: an analysis of two decades (1994-2014).

International journal for quality in health care : journal of the International Society for Quality in Health Care·2024
Same author

US Initiative to Eliminate Racial and Ethnic Disparities in Health: The Impact on the Outcomes of ST-Segment-Elevation Myocardial Infarction in New Jersey.

Journal of the American Heart Association·2023
Same author

Epidemiology and trends in stroke mortality in the USA, 1975-2019.

International journal of epidemiology·2022
Same author

Change and the Perils of Induction.

International journal of cardiology. Cardiovascular risk and prevention·2022
Same author

Relation of Socioeconomic Status to 1-Year Readmission and Mortality in Patients With Acute Myocardial Infarction.

The American journal of cardiology·2022
Same author

Assessment of one-year risk of ischemic stroke versus major bleeding in patients with atrial fibrillation.

International journal of cardiology. Cardiovascular risk and prevention·2022

Related Experiment Video

Updated: Apr 19, 2026

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery
05:19

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery

Published on: December 1, 2023

1.8K

Statins and Cataracts--a visual insight.

Jeanne M Dobrzynski1, John B Kostis

  • 1Cardiovascular Institute, Rutgers Robert Wood Johnson Medical School, 125 Paterson Street, CAB-5200, New Brunswick, NJ, 08901, USA.

Current Atherosclerosis Reports
|December 10, 2014
PubMed
Summary
This summary is machine-generated.

Statins may decrease cataract risk, particularly in younger individuals with longer therapy duration. Further research, including randomized trials, is needed to confirm this association and its clinical implications.

More Related Videos

Characterization of Molecular Mechanisms of In vivo UVR Induced Cataract
13:56

Characterization of Molecular Mechanisms of In vivo UVR Induced Cataract

Published on: November 28, 2012

10.5K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Related Experiment Videos

Last Updated: Apr 19, 2026

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery
05:19

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery

Published on: December 1, 2023

1.8K
Characterization of Molecular Mechanisms of In vivo UVR Induced Cataract
13:56

Characterization of Molecular Mechanisms of In vivo UVR Induced Cataract

Published on: November 28, 2012

10.5K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Epidemiology

Background:

  • Cataract is a leading cause of visual impairment and preventable blindness globally.
  • Statins, widely used for cardiovascular disease prevention, have potential adverse effects and debated associations with cataract formation.
  • Existing studies on statins and cataract report conflicting findings.

Purpose of the Study:

  • To investigate the relationship between statin use and the risk of developing cataracts.
  • To explore potential mechanisms, including pleiotropic effects, that might influence this relationship.
  • To identify factors, such as age and duration of therapy, that may modify the effect of statins on cataract risk.

Main Methods:

  • Review of existing publications and meta-analyses examining statin use and cataract incidence.
  • Analysis of potential biological mechanisms, including anti-inflammatory and antioxidant effects of statins.
  • Consideration of epidemiological study designs, such as randomized clinical trials, to definitively assess the association.

Main Results:

  • A meta-analysis suggested a 19% reduction in cataract risk among statin users.
  • Pleiotropic effects of statins (anti-inflammatory, antioxidant) may reduce cataract formation.
  • Younger age and longer statin therapy duration were associated with a greater observed benefit.

Conclusions:

  • The relationship between statins and cataract risk remains uncertain, with conflicting evidence.
  • Potential benefits, such as reduced cataract risk, could improve statin adherence.
  • Further definitive studies, like randomized clinical trials, are necessary to clarify the association.